Chiral-symmetry restoration in the linear sigma model at nonzero temperature and baryon density

We study the chiral phase transition in the linear sigma model with 2 quark flavors and $N_c$ colors. One-loop calculations predict a first-order phase transition at both $\mu=0$ and $\mu\neq 0$. We also discuss the phase diagram and make a comparison with a thermal parametrization of existing heavy-ion experimental data.Comment: 12 pages, 6 ps-figures, LaTe

The Chiral Fermion Meson Model at Finite Temperature

We study the chiral fermion meson model which is the well known linear sigma model of Gell-Mann-and-Levy at finite temperature.A modified self-consistent resummation (MSCR) which resums higher order terms in the perturbative expansion is proposed. It is shown that with the MSCR the problem of tachyonic masses is solved, the renormalization of the gap equations is carried out and the Goldstone's theorem is verified. We also apply the method to investigate another known case at high temperature and compare with results found in the literature.Comment: 31 pages, 9 EPS figures. Final version with extended Concluding Remarks section, accepted for publication in Phys. Rev.

The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019

BACKGROUND: Understanding the magnitude of cancer burden attributable to potentially modifiable risk factors is crucial for development of effective prevention and mitigation strategies. We analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 to inform cancer control planning efforts globally. METHODS: The GBD 2019 comparative risk assessment framework was used to estimate cancer burden attributable to behavioural, environmental and occupational, and metabolic risk factors. A total of 82 risk–outcome pairs were included on the basis of the World Cancer Research Fund criteria. Estimated cancer deaths and disability-adjusted life-years (DALYs) in 2019 and change in these measures between 2010 and 2019 are presented. FINDINGS: Globally, in 2019, the risk factors included in this analysis accounted for 4·45 million (95% uncertainty interval 4·01–4·94) deaths and 105 million (95·0–116) DALYs for both sexes combined, representing 44·4% (41·3–48·4) of all cancer deaths and 42·0% (39·1–45·6) of all DALYs. There were 2·88 million (2·60–3·18) risk-attributable cancer deaths in males (50·6% [47·8–54·1] of all male cancer deaths) and 1·58 million (1·36–1·84) risk-attributable cancer deaths in females (36·3% [32·5–41·3] of all female cancer deaths). The leading risk factors at the most detailed level globally for risk-attributable cancer deaths and DALYs in 2019 for both sexes combined were smoking, followed by alcohol use and high BMI. Risk-attributable cancer burden varied by world region and Socio-demographic Index (SDI), with smoking, unsafe sex, and alcohol use being the three leading risk factors for risk-attributable cancer DALYs in low SDI locations in 2019, whereas DALYs in high SDI locations mirrored the top three global risk factor rankings. From 2010 to 2019, global risk-attributable cancer deaths increased by 20·4% (12·6–28·4) and DALYs by 16·8% (8·8–25·0), with the greatest percentage increase in metabolic risks (34·7% [27·9–42·8] and 33·3% [25·8–42·0]). INTERPRETATION: The leading risk factors contributing to global cancer burden in 2019 were behavioural, whereas metabolic risk factors saw the largest increases between 2010 and 2019. Reducing exposure to these modifiable risk factors would decrease cancer mortality and DALY rates worldwide, and policies should be tailored appropriately to local cancer risk factor burden